52 related articles for article (PubMed ID: 16023976)
1. Use of growth factors with antiviral therapy for chronic hepatitis C.
Curry MP; Afdhal NH
Clin Liver Dis; 2005 Aug; 9(3):439-51, vii. PubMed ID: 16023976
[TBL] [Abstract][Full Text] [Related]
2. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
Sharvadze L; Gochitashvili N; Tophuria A; Bolokadze N; Tsertsvadze T
Georgian Med News; 2007 Jun; (147):52-5. PubMed ID: 17660602
[TBL] [Abstract][Full Text] [Related]
3. Management of the hematologic complications of hepatitis C therapy.
Sulkowski MS
Clin Liver Dis; 2005 Nov; 9(4):601-16, vi. PubMed ID: 16207566
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.
Smith JP
Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].
Gournay J; Richou C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B60-75. PubMed ID: 12180310
[No Abstract] [Full Text] [Related]
6. Ifn/Rbv treatment induced anemia and its correction with epoetin alpha in patients with hepatitis C.
Sharvadze L; Tsertsvadze T; Gochitashvili N; Kakabadze T; Dolmazashvili E
Georgian Med News; 2006 Aug; (137):62-5. PubMed ID: 16980747
[TBL] [Abstract][Full Text] [Related]
7. Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection.
Höroldt B; Haydon G; O'Donnell K; Dudley T; Nightingale P; Mutimer D
Liver Int; 2006 Aug; 26(6):650-9. PubMed ID: 16842320
[TBL] [Abstract][Full Text] [Related]
8. [The adherence in the treatment of chronic hepatitis C].
Pawłowska M; Halota W
Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis C virus infection in thalassemia.
Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
[TBL] [Abstract][Full Text] [Related]
12. Hematologic disorders associated with hepatitis C virus infection and their management.
Dieterich DT; Spivak JL
Clin Infect Dis; 2003 Aug; 37(4):533-41. PubMed ID: 12905138
[TBL] [Abstract][Full Text] [Related]
13. Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia.
Ong JP; Younossi ZM
Cleve Clin J Med; 2004 May; 71 Suppl 3():S17-21. PubMed ID: 15468613
[TBL] [Abstract][Full Text] [Related]
14. [Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].
Wejstål R; Fischler B; Glaumann H; Norkrans G; Reichard O; Sönnerborg A; Uhnoo I; Weiland O
Lakartidningen; 1999 Nov; 96(44):4795-8, 4800. PubMed ID: 10584541
[No Abstract] [Full Text] [Related]
15. Evaluating treatment of hepatitis C for hemolytic anemia management.
DebRoy S; Kribs-Zaleta C; Mubayi A; Cardona-Meléndez GM; Medina-Rios L; Kang M; Diaz E
Math Biosci; 2010 Jun; 225(2):141-55. PubMed ID: 20303990
[TBL] [Abstract][Full Text] [Related]
16. Treating hepatitis C: the state of the art.
Gish RG
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S1-9. PubMed ID: 15081099
[TBL] [Abstract][Full Text] [Related]
17. Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.
Mulhall BP; Younossi Z
J Clin Gastroenterol; 2005 Jan; 39(1 Suppl):S23-7. PubMed ID: 15597024
[TBL] [Abstract][Full Text] [Related]
18. The role of physician extenders in managing patients with chronic hepatitis C.
Gujral H; Viscomi C; Collantes R
Cleve Clin J Med; 2004 May; 71 Suppl 3():S33-7. PubMed ID: 15468616
[TBL] [Abstract][Full Text] [Related]
19. [Dermatitis associated with the treatment of chronic hepatitis C].
Lübbe J; Negro F
Rev Med Suisse; 2005 Apr; 1(16):1081-2, 1084-5. PubMed ID: 15934473
[TBL] [Abstract][Full Text] [Related]
20. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C].
Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ
Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
